An Overview of the Compounds Tested In Vivo for Leishmania spp. of the Last 5 Years.

CONCLUSION: Drug repurposing and new formulations of already-known drugs are worthwhile approaches to promptly introduce new treatment schemes to Leishmaniasis. Nevertheless, the interest in new synthetic compounds and new formulations brings light to new treatment proposals and are notable lines of research.
PMID: 33198609 [PubMed - as supplied by publisher]

Source: Current Medicinal Chemistry - November 16, 2020 Category: Chemistry Authors: de Barros Dias MCH, Freitas LAB, Dos Santos IR, de Almeida VS, do Amaral E Melo RT, de Melo Silva VG, de Santana BFM, da Conceição JM, Lima Leite AC Tags: Curr Med Chem Source Type: research